Literature DB >> 17492006

Azithromycin for control of trachoma.

S K West1.   

Abstract

Entities:  

Year:  1999        PMID： 17492006      PMCID： PMC1706032     

Source DB:  PubMed          Journal:  Community Eye Health        ISSN： 0953-6833


× No keyword cloud information.
  7 in total

1.  Ocular levels of azithromycin.

Authors:  K F Tabbara; S A al-Kharashi; S M al-Mansouri; O M al-Omar; H Cooper; A M el-Asrar; G Foulds
Journal:  Arch Ophthalmol       Date:  1998-12

2.  Extraocular infections in children in areas with endemic trachoma.

Authors:  R Malaty; S Zaki; M E Said; D W Vastine; D W Dawson; J Schachter
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

3.  The pharmacokinetics of azithromycin in human serum and tissues.

Authors:  G Foulds; R M Shepard; R B Johnson
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

4.  Azithromycin in control of trachoma.

Authors:  J Schachter; S K West; D Mabey; C R Dawson; L Bobo; R Bailey; S Vitale; T C Quinn; A Sheta; S Sallam; H Mkocha; D Mabey; H Faal
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

5.  Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Authors:  R L Bailey; P Arullendran; H C Whittle; D C Mabey
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321

6.  The epidemiology of trachoma in central Tanzania.

Authors:  S K West; B Munoz; V M Turner; B B Mmbaga; H R Taylor
Journal:  Int J Epidemiol       Date:  1991-12       Impact factor: 7.196

7.  Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study.

Authors:  K F Tabbara; A Abu-el-Asrar; O al-Omar; A H Choudhury; Z al-Faisal
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079
  7 in total
  10 in total

1.  Elimination of blinding trachoma in oman.

Authors:  Rajiv Khandekar
Journal:  Oman Med J       Date:  2009-04

2.  What's new in azithromyin?

Authors:  Anthony Solomon; Matthew Burton
Journal:  Community Eye Health       Date:  2004-12

3.  Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.

Authors:  Susannah McLean; Aziz Sheikh
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

4.  Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.

Authors:  Dominick L Opitz; Jennifer S Harthan
Journal:  Ophthalmol Eye Dis       Date:  2012-02-23

5.  Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections.

Authors:  Canan Asli Utine
Journal:  Clin Ophthalmol       Date:  2011-06-15

6.  Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.

Authors:  Mitchell H Friedlaender; Eugene Protzko
Journal:  Clin Ophthalmol       Date:  2007-03

Review 7.  Epidemiology and control of trachoma: systematic review.

Authors:  Victor H Hu; Emma M Harding-Esch; Matthew J Burton; Robin L Bailey; Julbert Kadimpeul; David C W Mabey
Journal:  Trop Med Int Health       Date:  2010-04-04       Impact factor: 2.622

8.  Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.

Authors:  Zelalem Tilahun; Teferi Gedif Fenta
Journal:  BMC Ophthalmol       Date:  2018-08-06       Impact factor: 2.209

9.  Knowledge, practices and perceptions of trachoma and its control among communities of Narok County, Kenya.

Authors:  Doris W Njomo; Jefitha Karimurio; Gladys O Odhiambo; Mukiri Mukuria; Ernest B Wanyama; Hillary K Rono; Micheal Gichangi
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-07-26

Review 10.  Azithromycin: The First Broad-spectrum Therapeutic.

Authors:  Anton Firth; Praveen Prathapan
Journal:  Eur J Med Chem       Date:  2020-08-19       Impact factor: 6.514
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.